Does LORAZEPAM Cause Poor venous access? 15 Reports in FDA Database

Q: Does LORAZEPAM cause Poor venous access?

15 reports of Poor venous access have been filed with the FDA for LORAZEPAM, representing 0.0% of all LORAZEPAM adverse event reports.

Q: How dangerous is Poor venous access from LORAZEPAM?

Of 15 reports, 1 (6.7%) resulted in death and 6 required hospitalization.

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Poor venous access have been filed in association with LORAZEPAM (Lorazepam). This represents 0.0% of all adverse event reports for LORAZEPAM.

Reports of Poor venous access with LORAZEPAM

0.0%

of all LORAZEPAM reports

Deaths

Hospitalizations

How Dangerous Is Poor venous access From LORAZEPAM?

Of the 15 reports, 1 (6.7%) resulted in death, 6 (40.0%) required hospitalization.

Is Poor venous access Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does LORAZEPAM Cause?

Drug ineffective (3,775) Drug abuse (3,741) Toxicity to various agents (2,836) Completed suicide (2,340) Off label use (2,178) Somnolence (2,114) Sopor (2,042) Anxiety (1,573) Fall (1,524) Overdose (1,516)

What Other Drugs Cause Poor venous access?

VEDOLIZUMAB (1,043) INFLIXIMAB (917) INFLIXIMAB-DYYB (782) ECULIZUMAB (555) HUMAN IMMUNOGLOBULIN G (504) NATALIZUMAB (422) RITUXIMAB (299) TOCILIZUMAB (287) METHOTREXATE (257) ABATACEPT (249)

Which LORAZEPAM Alternatives Have Lower Poor venous access Risk?

LORAZEPAM vs LORCASERIN LORAZEPAM vs LORLATINIB LORAZEPAM vs LORMETAZEPAM LORAZEPAM vs LORNOXICAM LORAZEPAM vs LOSARTAN

LORAZEPAM Full Profile All Poor venous access Reports All Drugs Causing Poor venous access LORAZEPAM Demographics